These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38110971)

  • 1. Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer.
    Mizobuchi T; Nomoto A; Wada H; Yamamoto N; Nakajima M; Fujisawa T; Suzuki H; Yoshino I
    Radiat Oncol; 2023 Dec; 18(1):201. PubMed ID: 38110971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
    Aokage K; Suzuki K; Saji H; Wakabayashi M; Kataoka T; Sekino Y; Fukuda H; Endo M; Hattori A; Mimae T; Miyoshi T; Isaka M; Yoshioka H; Nakajima R; Nakagawa K; Okami J; Ito H; Kuroda H; Tsuboi M; Okumura N; Takahama M; Ohde Y; Aoki T; Tsutani Y; Okada M; Watanabe SI;
    Lancet Respir Med; 2023 Jun; 11(6):540-549. PubMed ID: 36893780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of surgical outcomes and prognosis between wedge resection and simple Segmentectomy for GGO diameter between 2 cm and 3 cm in non-small cell lung cancer: a multicenter and propensity score matching analysis.
    Zhou Y; Yu T; Zhang Y; Qian L; Xia Q
    BMC Cancer; 2022 Jan; 22(1):71. PubMed ID: 35034626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intentional wedge resection versus segmentectomy for ≤2 cm ground-glass-opacity-dominant non-small cell lung cancer: a real-world study using inverse probability of treatment weighting.
    Liu C; Yang Z; Li Y; Guo C; Xia L; Zhang W; Xiao C; Mei J; Liao H; Zhu Y; Lin F; Ma L; Pu Q; Liu L
    Int J Surg; 2024 Jul; 110(7):4231-4239. PubMed ID: 38518080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Experience with Video-Assisted Thoracoscopic Anatomic Segmentectomy.
    Yao F; Wang J; Yao J; Xu L; Qian J; Cao Y
    J Laparoendosc Adv Surg Tech A; 2018 Jul; 28(7):819-826. PubMed ID: 29424636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
    Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity.
    Iwata H; Shirahashi K; Mizuno Y; Yamamoto H; Takemura H
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):375-9; discussion 379. PubMed ID: 24562008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
    Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
    J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in Survival Prognosis of Segmentectomy for 
Early-stage Non-small Cell Lung Cancer].
    Rao S; Ye L; Cui X; Sun Q; Cao R; Xiao S; Yang J; Wang W; Zhao G; Huang Y
    Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):830-836. PubMed ID: 32957171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
    Li Z; Xu W; Pan X; Wu W; Chen L
    Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
    Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
    J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ground glass opacity resection extent assessment trial
    Li H; Wang Y; Chen Y; Zhong C; Fang W
    Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
    Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
    Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
    Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
    Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.